drugset / Trial / NCT00338923

Wound Healing Effects of HO/03/03 In Patients With Diabetic Neuropathic Plantar and Venous Ulcers, Pilot Study.

NCT00338923 ↗

Phase 1 Completed 22 enrolled HealOr
NaSingle-groupOpen-labelTreatment

Summary

This is a multicenter pilot study to assess the healing effects of HO/03/03 on diabetic neuropathic plantar and venous ulcers. HO/03/03 action mechanism involves the manipulation of keratinocyte and fibroblast migration and differentiation at the wound area. * The primary end point of this study is assessment of safety in treating with HO/03/03 and the efficacy of the drug to promote wound closure of chronic wounds. * The secondary end points are assessment time to closure and healing rate for the measurement of wound healing progression.

Timeline

Start
2006-06
Primary completion
—
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator HO/03/03 Unknown — Topical

Indications